Table 4.
Nonadherence to laboratory testing for completed visits in 2019 and 2020.
| Laboratory studies not completed within 30 days of appointment | Total visits in 2019 (n=257), n (%) | Total visits in 2020 (n=289), n (%) | P valuea | In-person visits in 2020 (n=136), n (%) | Telemedicine visits in 2020 (n=153), n (%) | P valuea |
| CBCb | 7 (2.7) | 4 (1.4) | .28 | 0 (0) | 4 (2.6) | N/Ac |
| BMPd or CMPe | 5 (1.9) | 7 (2.4) | .71 | 2 (1.5) | 5 (5.3) | .33 |
| Urinalysis | 7 (2.7) | 38 (13.1) | <.001 | 16 (11.8) | 22 (14.4) | .51 |
| Anti-dsDNAf | 19 (7.4) | 17 (5.9) | .48 | 4 (2.9) | 13 (8.5) | .06 |
| Complements | 9 (3.5) | 18 (6.2) | .15 | 5 (3.7) | 13 (8.5) | .10 |
aCalculated using a generalized estimating equation with an independent correlation structure.
bCBC: complete blood count.
cN/A: not applicable.
dBMP: basic metabolic panel.
eCMP: comprehensive metabolic panel.
fAnti-dsDNA: anti–double-stranded DNA.